Fosun Pharmaceuticals: Fosun Pharmaceuticals: Legal Opinion of Attorney Guo Hao (Shanghai) Office on the implementation of partial restricted stock repurchases and cancellation of the 2022 Restricted A-share Stock Incentive Plan of Shanghai Fosun Pharmaceuticals (Group) Co., Ltd.

SZSI · Sep 27

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

复星医药：复星医药：国浩律师(上海)事务所关于上海复星医药（集团）股份有限公司2022年限制性A股股票激励计划部分限制性股票回购注销实施情况的法律意见书

Fosun Pharmaceuticals: Fosun Pharmaceuticals: Legal Opinion of Attorney Guo Hao (Shanghai) Office on the implementation of partial restricted stock repurchases and cancellation of the 2022 Restricted A-share Stock Incentive Plan of Shanghai Fosun Pharmaceuticals (Group) Co., Ltd.

Risk Disclaimer

Statement